Target intelligence / Profile preview

Suppressor of tumorigenicity 20 protein (ST20)

Target
ST20
Molecular classification
Other (Tumor suppressor protein)
01

Overview

Suppressor of tumorigenicity 20 protein (ST20) is a human protein thought to function as a tumor suppressor. It may promote apoptosis of cancer cells and is associated with cellular responses to genotoxic stress such as UV-C exposure. Alternative names reflect its discovery as a suppressor gene in cervical cancer. Its precise molecular mechanisms are not fully characterized, but it has been suggested to serve in apoptotic signaling pathways, possibly regulating cysteine-type endopeptidase activators. Aberrations including gene fusions or loss-of-function mutations may contribute to tumorigenesis, especially in carcinomas such as cervical cancer. Further research is required to establish its utility as a biomarker or a drug target, and to elucidate mechanisms relevant for therapeutic exploitation.

Other names
HCCS-1HCCS1Human cervical cancer suppressor gene 1 proteincervical cancer suppressor-1human cervical cancer suppressor 1human cervical cancer suppressor gene 1 proteinsuppressor of tumorigenicity 20 proteinST20
02

Biological functions

ApoptosisCell deathMay act as a transcriptional repressor
03

Disease associations

Cancer (especially cervical cancer, potentially other carcinomas)
04

Safety considerations

Potential for therapeutic resistance or off-target effects if used in gene therapy; further study required for protein/peptide-based therapies

Beyond the preview

Go deeper on Suppressor of tumorigenicity 20 protein (ST20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suppressor of tumorigenicity 20 protein (ST20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call